S&P 500 falls after giving up gains as Oracle slump weighs on tech
Michael W. DePasquale, Chief Executive Officer and Chairman of BIO KEY INTERNATIONAL INC (NASDAQ:BKYI), has recently purchased company shares, a notable move given that InvestingPro analysis indicates the stock is currently undervalued. The company, with a market capitalization of $5.49 million, has seen its stock decline to just 22% of its 52-week high of $3.68. According to a Form 4 filing with the Securities and Exchange Commission, DePasquale acquired a total of 4,117 shares of common stock in two transactions.
On September 15, 2025, DePasquale bought 2,500 shares at $0.75 per share. The following day, September 16, 2025, he purchased an additional 1,617 shares at $0.84 per share. The total value of these purchases is $3233, with prices ranging from $0.75 to $0.84. The timing of these purchases coincides with a strong monthly return for the stock, according to InvestingPro data, which offers comprehensive insider trading analysis and 10+ additional investment tips for BKYI.
Following these transactions, DePasquale directly owns 112,174 shares of BIO KEY INTERNATIONAL INC. This figure does not include options to purchase 232 shares and 9,167 shares issuable upon exercise of warrants.
In other recent news, BIO-key International Inc. reported a notable 49% increase in revenue for the second quarter of 2025 compared to the same period last year. Despite this revenue surge, broader market conditions have influenced investor sentiment. Additionally, BIO-key International held its annual meeting where shareholders approved all proposals, including the election of five directors to serve one-year terms on the board. The directors elected are Michael W. DePasquale, Wong Kwok Fong (Kelvin), Robert J. Michel, Emmanuel Alia, and Cameron E. Williams. Vote totals for each nominee ranged from 995,776 to 1,001,229 in favor, with 299,168 to 304,621 votes withheld. These developments reflect the company’s ongoing efforts to strengthen its governance and financial performance. Investors and stakeholders continue to monitor the company’s strategic decisions and market conditions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.